European Biotech Acquisition Corp. Units

NASDAQ: EBACU  - / - / -
10.00-0.0500-0.50%Vol 15.50K1Y Perf 0.00%
Jun 15th, 2021 18:55 DELAYED
BID9.96 ASK10.05
Open10.00 Previous Close10.05
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap- 
Earnings Rating
Price Range Ratio 52W %
31.94 
Earnings Date
-

Today's Price Range

10.0010.00

52W Range

9.7710.49

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
0.00%
1 Month
0.00%
3 Months
-0.10%
6 Months
-
1 Year
0.00%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
EBACU10.00-0.0500-0.50
AAPL130.46-1.3300-1.01
GOOG2 511.35-16.0700-0.64
MSFT259.43-1.4700-0.56
XOM60.40-1.5900-2.56
WFC41.75-1.0400-2.43
JNJ161.98-3.2400-1.96
FB329.66-6.8500-2.04
GE12.78-0.2200-1.69
JPM147.92-3.8400-2.53
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume15.50K
Shares Outstanding0
Trades Count0
Dollar Volume0
Avg. Volume63.18K
Avg. Weekly Volume28.48K
Avg. Monthly Volume13.74K
Avg. Quarterly Volume63.18K

European Biotech Acquisition Corp. Units (NASDAQ: EBACU) stock closed at 9.99 per share at the end of the most recent trading day (a -0.5% change compared to the prior day closing price) with a volume of 102.0000 shares and market capitalization of 0.0000. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the industry, sector and employs 0 people. European Biotech Acquisition Corp. Units CEO is .

The one-year performance of European Biotech Acquisition Corp. Units stock is 0%, while year-to-date (YTD) performance is %. EBACU stock has a five-year performance of %. Its 52-week range is between 9.77 and 10.49, which gives EBACU stock a 52-week price range ratio of 31.94%

European Biotech Acquisition Corp. Units currently has a PE ratio of -, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -17.13%, a ROC of -% and a ROE of -69.35%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from European Biotech Acquisition Corp. Units, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. European Biotech Acquisition Corp. Units’s next earnings report date is -.

The consensus rating of Wall Street analysts for European Biotech Acquisition Corp. Units is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for European Biotech Acquisition Corp. Units stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

European Biotech Acquisition Corp. Units has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

European Biotech Acquisition Corp. Units has a Neutral technical analysis rating based on Technical Indicators (ADX : 13.59, ATR14 : 0.06, CCI20 : 76.47, Chaikin Money Flow : -0.12, MACD : 0.00, Money Flow Index : 18.17, ROC : 0.00, RSI : 51.78, STOCH (14,3) : 70.59, STOCH RSI : 0.60, UO : 60.13, Williams %R : -29.41), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of European Biotech Acquisition Corp. Units in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

European Biotech Acquisition Corp. Units

CEO:

Telephone:

Address: , , ,

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

News

Stocktwits